or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN D -0.82 8.14
    GILD B -0.12 7.41
    VRTX D -0.94 7.21
    BIIB F -0.18 6.12
    ILMN C 0.51 5.67
    REGN F -0.48 4.13
    INCY C -0.77 2.09
    BMRN F -1.37 1.91
    ALNY D 0.44 1.60
    VTRS A 0.04 1.35
    SNY F 0.06 1.29
    NBIX C 0.36 1.16
    SRPT F -1.18 1.15
    NVCR C -1.36 1.10
    JAZZ B 1.59 1.03
    TECH F 1.67 1.02
    IONS F 0.00 1.02
    GH B 0.93 0.96
    AMRN F 1.13 0.85
    MRNA F 0.35 0.83
    BGNE D 0.12 0.83
    ACAD C -3.41 0.81
    ASND F -0.85 0.77
    EXEL B -0.20 0.73
    ARWR D -1.55 0.65
    BLUE F -2.51 0.65
    BBIO F -0.26 0.51
    ALLK D 0.00 0.49
    UTHR C 0.03 0.49
    NKTR F 0.50 0.48
    SAGE F 2.24 0.48
    BPMC C -0.54 0.48
    FGEN F 4.94 0.47
    AGIO C -0.64 0.43
    CRSP D -3.26 0.42
    RARE F 0.70 0.42
    ADPT C -0.68 0.42
    MEDP F 2.55 0.40
    PTCT B 0.39 0.40
    ARGX A 0.18 0.40
    AXSM B 0.36 0.38
    ALLO F -0.98 0.37
    GRFS C -3.26 0.36
    IOVA F 0.33 0.36
    ALKS C -0.81 0.36
    KOD B -0.69 0.35
    HALO F -0.96 0.35
    QURE D -0.70 0.35
    FOLD F -1.41 0.32
    APLS F -2.29 0.31
    XNCR B -0.21 0.26
    MYGN F 0.42 0.26
    DNLI D -1.11 0.26
    ZLAB C 0.00 0.24
    IRWD F -3.69 0.24
    ARVN F 1.81 0.24
    INSM C -1.21 0.23
    FATE F -3.15 0.23
    PCRX C 0.76 0.22
    GLPG F -1.33 0.22
    ITCI B -1.24 0.21
    RGNX D -2.60 0.21
    ESPR B -1.45 0.19
    EDIT F -3.73 0.19
    LGND C 0.51 0.19
    INVA D -0.73 0.18
    VCYT B 0.15 0.18
    ALEC F -2.20 0.18
    TBPH B -0.70 0.17
    YMAB F -0.14 0.16
    CHRS D -2.73 0.16
    HCM C -0.78 0.15
    SUPN B -0.91 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain Immunology Infectious Diseases S&P 500 Disease Genetics Immune System Inflammation Nasdaq 100 Organ Systems Cholesterol Monoclonal Antibodies Monoclonal Antibody
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
    Nov 21 TECH Temu Parent PDD Stock Tumbles After Q3 Profit Miss, Company Cites Intensified Competition and External Challenges
    Nov 21 TECH How To Earn $500 A Month From Intuit Stock Ahead Of Q1 Earnings
    Nov 21 ESPR Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
    Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 TECH Tesla Registrations Drop By Over 20% In October In EU, Possibly Hindering Its 2024 Global EV Delivery Target
    Nov 21 TECH SpaceX CEO Elon Musk Reveals Technical Glitch That Led Company To Drop Key Objective Of Starship's 6th Test Flight
    Nov 21 TECH Ray Dalio Says Pro-Trump Tech Companies Stand To Gain As Focus Shifts To Deregulation: Here's How Investors Should Brace For Impact
    Nov 21 TECH SafeRent Settles $2.3M Discrimination Lawsuit Over Alleged AI Screening Bias Against Low-Income Renters
    Nov 21 TECH Google's 'Unlawful Behavior' Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly
    Nov 21 TECH Tesla Now Allows Users To Report Snow Accumulation, Blocked Stalls And Other Supercharger Issues Ahead Of Winter
    Nov 21 TECH Why SpaceX Opted For Standard Starship Landing Over Elon Musk's Innovative 'Chopsticks' Technique
    Nov 21 TECH Ford's JV Battery Plant In Kentucky Faces Unionization As 'Supermajority' Of Workers Sign Union Authorization Cards, Says UAW
    Nov 21 TECH Nvidia's Blackwell Set To Outpace Hopper? Here's What CEO Jensen Huang Predicts For 2025
    Nov 21 TECH Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'
    Nov 21 TECH Nvidia CEO Jensen Huang Says The Present Time Is 'The Beginnings Of Two Fundamental Shifts In Computing' As Blackwell Powers Explosive AI Demand
    Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...